arrow
B

Bryan Coburn

University Health Network
H指数:38
被引数:6,529

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Association of Antianaerobic Antibiotics With Mortality and the Gut Microbiome: A Substudy of the BALANCE Randomized Clinical Trial

抗厌氧菌抗生素与死亡率和肠道微生物组的关联:BALANCE随机临床试验的子研究

2026-08-040
OAAI
Assessing the feasibility of a platform trial for Gram negative bloodstream infections: results from the vanguard phase of BALANCE

评估阴性菌血流感染平台试验的可行性:BALANCE先锋期结果

2025-12-040
OA
Cohort-level clinical trajectory and molecular landscape of idiopathic subglottic stenosis for precision laryngology-a study of the Canadian airways research (CARE) group

队列水平的特发性声门下狭窄临床轨迹与分子景观:一项加拿大气道研究(CARE)小组的精准喉科学研究

2025-04-012
OAAI
Microbial Ecosystem Therapeutics 4 (MET4) elicits treatment-specific IgG responses associated with changes in gut microbiota in immune checkpoint inhibitor recipients with advanced solid tumors

微生物生态系统疗法4 (MET4) 可引发接受免疫检查点抑制剂治疗的有进展期实体瘤患者的、与肠道菌群变化相关的特定治疗性IgG反应。

2025-03-220
OA
Impact of Antibiotic Duration on Gut Microbiome Composition and Antimicrobial Resistance: A Substudy of the BALANCE Randomized Controlled Trial

抗生素疗程对肠道微生物组组成及抗菌药物耐药性的影响:BALANCE随机对照试验的子研究

2025-03-140
OA
Prospective manipulation of the gut microbiome with microbial ecosystem therapeutic 4 (MET4) in HPV-related locoregionally-advanced oropharyngeal cancer squamous cell carcinoma (LA-OPSCC) undergoing primary chemoradiation: ROMA2 study
2024-05-071
PRE
Autoimmune PaneLs as PrEdictors of Toxicity in Patients TReated with Immune Checkpoint InhibiTors (ALERT)
2023-10-211
OAAI
First-in-class Microbial Ecosystem Therapeutic 4 (MET4) in combination with immune checkpoint inhibitors in patients with advanced solid tumors (MET4-IO trial)

先进的微生物生态系统治疗剂4 (MET4) 联合免疫检查点抑制剂治疗晚期实体瘤 (MET4-IO试验)

2023-06-0129
OAAI